Abstract:Objective: Repetitive transcranial magnetic stimulation (rTMS) has recently emerged as a novel treatment option for patients with major depressive disorder (MDD), but clinical observations reveal variability in patient's responses to rTMS. Therefore, it is clinically significant to investigate the baseline neuroimaging differences between patients with (Responder) and without (NonResponder) response to rTMS treatment and predict rTMS treatment outcomes based on baseline neuroimaging data. Method: Baseline resting-state EEG data and Beck Depression Inventory (BDI) were collected from 74 rTMS Responder, 43 NonResponder, and 47 matched healthy controls (HC). EEG microstate analysis was applied to analyze common and differential microstate characteristics of Responder and NonResponder. In addition, the microstate temporal parameters were sent to four machine learning models to classify Responder from NonResponder. Result: There exists some common and differential EEG microstate characteristics for Responder and NonResponder. Specifically, compared to the HC group, both Responder and NonResponder exhibited a significant increase in the occurrence of microstate A. Only Responder showed an increase in the coverage of microstate A, occurrence of microstate D, transition probability (TP) from A to D, D to A, and C to A, and a decrease in the duration of microstates B and E, TP from A to B and C to B compared to HC. Only NonResponder exhibited a significant decrease in the duration of microstate D, TP from C to D, and an increase in the occurrence of microstate E, TP from C to E compared to HC. The primary differences between the Responder and NonResponder are that Responder had higher parameters for microstate D, TP from other microstates to D, and lower parameters for microstate E, TP from other microstates to E compared to NonResponder. Baseline parameters of microstate D showed significant correlation with Beck Depression Inventory (BDI) reduction rate. Additionally, these microstate features were sent to four machine learning models to predict rTMS treatment response and classification results indicate that an excellent predicting performance (accuracy = 97.35 %, precision = 96.31 %, recall = 100 %, F1 score = 98.06 %) was obtained when using AdaBoost model. These results suggest that baseline resting-state EEG microstate parameters could serve as robust indicators for predicting the effectiveness of rTMS treatment. Conclusion: This study reveals significant baseline EEG microstate differences between rTMS Responder, NonResponder, and healthy controls. Microstates D and E in baseline EEG can serve as potential biomarkers for predicting rTMS treatment outcomes in MDD patients. These findings may aid in identifying patients likely to respond to rTMS, optimizing treatment plans and reducing trial-and-error approaches in therapy selection.

Pretreatment predictors of early response revealed by quantitative cerebral blood flow in major depressive disorder

Distinct Features of Cerebral Blood Flow and Spontaneous Neural Activity as Integrated Predictors of Early Response to Antidepressants.

Predict Value of Functional Topological Features for Early Response to Antidepressant Treatment in Major Depressive Disorder

Distinctive Pretreatment Features of Bilateral Nucleus Accumbens Networks Predict Early Response to Antidepressants in Major Depressive Disorder

Electrophysiological predictors of early response to antidepressants in major depressive disorder

Divergent Topological Architecture of the Default Mode Network As a Pretreatment Predictor of Early Antidepressant Response in Major Depressive Disorder

Increased Temporal Variability of Striatum Region Facilitating the Early Antidepressant Response in Patients with Major Depressive Disorder

Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder

Sub-hubs of Baseline Functional Brain Networks Are Related to Early Improvement Following Two-Week Pharmacological Therapy for Major Depressive Disorder.

Common and differential EEG microstate of major depressive disorder patients with and without response to rTMS treatment

Cerebral Blood Flow Perfusion in Patients with Depressive Disorder Associated with Depression Using SPECT

Abnormal Hippocampal Subfields May Be Potential Predictors of Worse Early Response to Antidepressant Treatment in Drug‐Naïve Patients with Major Depressive Disorder

Identification of Major Depressive Disorder and Prediction of Treatment Response Using Functional Connectivity Between the Prefrontal Cortices and Subgenual Anterior Cingulate: A Real-World Study

Local and large-scale resting-state oscillatory dysfunctions for early antidepressant response prediction in major depressive disorder

SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli

Prognostic value of imbalanced interhemispheric functional coordination in early therapeutic efficacy in major depressive disorder

Distinct MRI-based functional and structural connectivity for antidepressant response prediction in major depressive disorder

A multivariate neuroimaging biomarker of individual outcome to transcranial magnetic stimulation in depression

Variance of the global signal as a pretreatment predictor of antidepressant treatment response in drug-naïve major depressive disorder

Brain Grey Matter Volume Alterations Associated with Antidepressant Response in Major Depressive Disorder.

Correlation Between Functional Connectivity of the Precuneus and Early Efficacy to Antidepressant Treatment in Patients of Major Depressive Disorder